308 related articles for article (PubMed ID: 22257040)
1. Is FENO50 useful diagnostic tool in suspected asthma?
Schleich FN; Asandei R; Manise M; Sele J; Seidel L; Louis R
Int J Clin Pract; 2012 Feb; 66(2):158-65. PubMed ID: 22257040
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of exhaled nitric oxide for diagnosing asthma.
Pedrosa M; Cancelliere N; Barranco P; López-Carrasco V; Quirce S
J Asthma; 2010 Sep; 47(7):817-21. PubMed ID: 20718633
[TBL] [Abstract][Full Text] [Related]
3. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.
Quaedvlieg V; Sele J; Henket M; Louis R
Clin Exp Allergy; 2009 Dec; 39(12):1822-9. PubMed ID: 19817755
[TBL] [Abstract][Full Text] [Related]
4. Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms.
Heffler E; Guida G; Marsico P; Bergia R; Bommarito L; Ferrero N; Nebiolo F; De Stefani A; Usai A; Bucca C; Rolla G
Respir Med; 2006 Nov; 100(11):1981-7. PubMed ID: 16584881
[TBL] [Abstract][Full Text] [Related]
5. Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma.
Woo SI; Lee JH; Kim H; Kang JW; Sun YH; Hahn YS
Respir Med; 2012 Aug; 106(8):1103-9. PubMed ID: 22534041
[TBL] [Abstract][Full Text] [Related]
6. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests.
Berkman N; Avital A; Breuer R; Bardach E; Springer C; Godfrey S
Thorax; 2005 May; 60(5):383-8. PubMed ID: 15860713
[TBL] [Abstract][Full Text] [Related]
7. The FEF25-75 and its decline as a predictor of methacholine responsiveness in children.
Drewek R; Garber E; Stanclik S; Simpson P; Nugent M; Gershan W
J Asthma; 2009 May; 46(4):375-81. PubMed ID: 19484673
[TBL] [Abstract][Full Text] [Related]
8. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide.
Aronsson D; Tufvesson E; Bjermer L
Clin Exp Allergy; 2005 Nov; 35(11):1457-61. PubMed ID: 16297142
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added].
Schneider A; Tilemann L; Schermer T; Gindner L; Laux G; Szecsenyi J; Meyer FJ
Respir Res; 2009 Mar; 10(1):15. PubMed ID: 19254389
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Methacholine Challenge Testing and exhaled nitric oxide in adult patients with suspected bronchial asthma.
Giovannini M; Valli M; Ribuffo V; Melara R; Cappiello G; Businarolo E; Andreani A
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):109-13. PubMed ID: 24853569
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.
Pijnenburg MW; Hofhuis W; Hop WC; De Jongste JC
Thorax; 2005 Mar; 60(3):215-8. PubMed ID: 15741438
[TBL] [Abstract][Full Text] [Related]
12. FENO measurement and sputum analysis for diagnosing asthma in clinical practice.
Schneider A; Schwarzbach J; Faderl B; Welker L; Karsch-Völk M; Jörres RA
Respir Med; 2013 Feb; 107(2):209-16. PubMed ID: 23107283
[TBL] [Abstract][Full Text] [Related]
13. Comparison of percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV(1) between patients with asymptomatic bronchial hyperresponsiveness and mild asthma.
Yoo Y; Choung JT; Yu J; Kim DK; Choi SH; Koh YY
Chest; 2007 Jul; 132(1):106-11. PubMed ID: 17505037
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of different diagnostic tests in adult mild asthmatic patients: comparison with patients with asthma-like symptoms by gastro-oesophageal reflux.
Di Lorenzo G; Mansueto P; Esposito-Pellitteri M; Ditta V; Castello F; Lo Bianco C; Leto-Barone MS; Di Fede G; Traverso M; Rotolo G; Vigneri S; Rini G
Respir Med; 2007 Jul; 101(7):1455-61. PubMed ID: 17360170
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis.
Mahut B; Plantier L; Malinvaud D; Chevalier-Bidaud B; Bonfils P; Delclaux C
Respir Med; 2012 Jan; 106(1):68-74. PubMed ID: 21855311
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of peak flow variability in patients with suspected diagnosis of bronchial asthma in general practice].
Tilemann L; Gindner L; Meyer FJ; Laux G; Szecsenyi J; Schneider A
Dtsch Med Wochenschr; 2009 Oct; 134(41):2053-8. PubMed ID: 19802765
[TBL] [Abstract][Full Text] [Related]
17. Can exhaled nitric oxide be a surrogate marker of bronchial hyperresponsiveness to adenosine 5'-monophosphate in steroid-naive asthmatic children?
Arga M; Bakirtas A; Topal E; Turktas I
Clin Exp Allergy; 2015 Apr; 45(4):758-66. PubMed ID: 25378028
[TBL] [Abstract][Full Text] [Related]
18. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control.
Melosini L; Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Paggiaro P
J Asthma; 2012 Apr; 49(3):317-23. PubMed ID: 22401649
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count.
Fortuna AM; Feixas T; González M; Casan P
Respir Med; 2007 Nov; 101(11):2416-21. PubMed ID: 17714927
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
